Sep 1, 2026 07:00AM
Sep 1, 2026 07:00AM
Sep 1, 2026 06:09AM
Aug 27, 2026 07:00AM
Aug 26, 2026 09:20AM
Aug 26, 2026 07:00AM
Aug 26, 2026 07:00AM TROPION-Urothelial04 Phase 3 Trial of Datroway® Initiated as Adjuvant Therapy in Patients with High-Risk Muscle Invasive Urothelial Cancer
Aug 17, 2026 07:30AM
Aug 17, 2026 07:00AM
Aug 17, 2026 02:30AM
Aug 17, 2026 02:30AM
Jul 27, 2026 06:06AM
Jun 22, 2026 08:30AM
Jun 15, 2026 03:00AM AstraZeneca unit receives FDA priority review for rare kidney disease treatment
Jun 12, 2026 06:44PM
Jun 12, 2026 02:03PM
Jun 2, 2026 08:02AM
Jun 1, 2026 08:01AM
Jun 1, 2026 08:00AM
May 28, 2026 09:18PM
May 28, 2026 12:42PM FDA Approves Durvalumab in Combination with Bacillus Calmette-Guerin for High-Risk Non-Muscle Invasive Bladder Cancer
May 27, 2026 04:04AM
May 22, 2026 10:17AM
May 22, 2026 10:16AM
May 22, 2026 09:30AM
May 22, 2026 09:30AM
May 22, 2026 08:00AM
May 22, 2026 08:00AM Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors
May 22, 2026 07:00AM
May 22, 2026 07:00AM
May 18, 2026 07:00AM
May 18, 2026 07:00AM
May 18, 2026 05:07AM
May 15, 2026 09:52PM
May 15, 2026 06:31PM Enhertu® Approved in the U.S. for Two New Indications for Patients with HER2 Positive Early Breast Cancer
May 14, 2026 07:00AM
May 1, 2026 05:44AM
Apr 30, 2026 09:42PM
Apr 30, 2026 11:49AM
Apr 28, 2026 01:46PM
Apr 28, 2026 07:03AM
Apr 28, 2026 07:00AM BREZTRI approved in the US for asthma as first and only triple therapy for patients 12 years of age and older
Apr 27, 2026 07:03AM
Apr 27, 2026 07:00AM
Apr 20, 2026 07:01AM
Apr 7, 2026 02:09PM
Apr 2, 2026 07:00AM
Apr 2, 2026 07:00AM
Mar 24, 2026 10:30AM Advancements in Novel Immunotherapeutics in The Oncology Battle
Mar 9, 2026 08:45AM

329,928 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All